KP Tissue Inc. (TSE:KPT – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$11.57 and traded as high as C$12.91. KP Tissue shares last traded at C$12.90, with a volume of 22,953 shares trading hands.
Analyst Ratings Changes
A number of equities analysts have weighed in on KPT shares. Desjardins boosted their target price on shares of KP Tissue from C$12.00 to C$12.50 and gave the stock a “hold” rating in a research note on Friday, May 15th. TD raised their price target on shares of KP Tissue from C$12.00 to C$14.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. Three investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of C$12.12.
Read Our Latest Research Report on KPT
KP Tissue Trading Up 0.2%
KP Tissue (TSE:KPT – Get Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported C$0.22 earnings per share for the quarter. Equities analysts forecast that KP Tissue Inc. will post 0.4398964 earnings per share for the current fiscal year.
KP Tissue Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 15th were paid a $0.21 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $0.84 annualized dividend and a yield of 6.5%. KP Tissue’s payout ratio is presently 80.00%.
Insiders Place Their Bets
In other KP Tissue news, Director David A. Spraley sold 3,668 shares of the company’s stock in a transaction that occurred on Wednesday, June 17th. The stock was sold at an average price of C$13.30, for a total transaction of C$48,784.40. Following the completion of the transaction, the director owned 15,712 shares of the company’s stock, valued at C$208,969.60. This represents a 18.93% decrease in their position. Over the last three months, insiders sold 6,668 shares of company stock worth $87,644. Corporate insiders own 0.14% of the company’s stock.
KP Tissue Company Profile
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Further Reading
- Five stocks we like better than KP Tissue
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
